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Abstract
Background: Familial hypercholesterolemia (FH) is a heritable disorder that can increase the risk of premature coronary
heart disease. Studies suggest there are substantial genetic heterogeneities for different populations. Here we tried to
identify novel susceptibility loci for FH in a Chinese pedigree.
Methodology/Principal Findings: We performed a SNP-based genome-wide linkage scan with the Chinese FH pedigree.
Two suggestive linkage loci not previously reported were identified on chromosomes 3q25.1-26.1 (NPL=9.01, nominal
P,0.00001, and simulated occurrence per genome scan=1.08) and 21q22.3 (NPL=8.95, nominal P,0.00001, and simulated
occurrence per genome scan=1.26). In the interaction analysis with a trimmed version of the pedigree, we obtained a
significantly increased joint LOD score (2.70) compared with that obtained when assuming the two loci uncorrelated,
suggesting that more than one locus was involved in this pedigree. Exon screening of two candidate genes ABCG1 and LSS
from one of the suggestive region 21q22 didn’t report any causative mutations.
Conclusions/Significances: These results confirm complex etiologies and suggest new genetic casual factors for the FH
disorder. Further study of the two candidate regions is advocated.
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Introduction
Familial hypercholesterolemia (FH) is a heritable disorder
characterized by high concentration of total cholesterol and low
density lipoprotein cholesterol in serums. Elevated levels of
cholesterol can give rise to xanthomas, a deposit of cholesterol
in peripheral tissues, accelerating atherosclerosis, and therefore
increase the risk of premature coronary heart disease (CHD) [1].
The FH phenotype is affected by both environmental and genetic
factors [2].
The majority of FH cases are transmitted in an autosomal-
dominant manner, known as autosomal dominant hypercholes-
terolemia (ADH or FH, MIM ID #143890). Three genes
identified in autosomal dominant FH disorder are the low density
lipoprotein receptor gene (LDLR) on chromosome 19 [3], the
apolipoprotein B gene (APOB) on chromosome 2 [4], and the
proprotein convertase subtilisin/kexin type 9 gene (PCSK9)o n
chromosome 1 [5]. Other FH loci currently listed in OMIM
include 1q21-q23, 9q22-q31, 8p21-p12, 7p15, 5p13-p12, 3p21.2-
p14.1, and 19p13.2 (MIM ID #143890). Autosomal recessive
inheritance, referred to as autosomal recessive hypercholesterol-
emia (ARH, MIM ID #603813), was also observed in some
pedigrees. Thus far only one ARH locus, 1p36-35 [6,7], is listed in
OMIM, although two other loci for ARH, located on 13q22-32
[7] and 15q25-26 [8], have also been reported.
Genetic heterogeneity for FH among different populations
provides the possibility of uncovering other uncharacterized genes
that may be involved in the pathogenesis of the disease. For
example, in a Mexican population, no PCSK9 mutations were
found in one large FH family that showed positive linkage to the
1p34.1-32 locus; this indicates genes other than PCSK9 in the locus
may be involved [9]. In addition, a Portuguese FH study found
only 48% of its total received cases with clinical diagnosis of FH
had genetic defects on LDLR, APOB or PCSK9, leaving the other
52% of FH cases with possible undiscovered gene mutations [10].
To identify novel FH loci in Chinese individuals, we performed
a genome-wide linkage analysis of a Chinese pedigree without the
known FH mutations in LDLR, APOB, and PCSK9, using an
Illumina Human Linkage-12 panel, which contains 6,090 SNP
markers with an average spacing of 0.58 cM. A two-locus linkage
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linkage signals and potential locus interaction.
Results
Plasma lipid concentrations and clinical characteristics
Lipid levels and clinical features including xanthoma and
coronary heart disease (CHD) for the pedigree members are
shown in Table 1. Without lipid-lowering drug therapy, the
plasma total cholesterol levels of these patients ranged from 226.9
to 817.2 mg/dl and the levels of LDL cholesterol ranged from
122.6 to 761.1 mg/dl. Clinical manifestations of the proband are
shown in Figure 1. Patient 209 died of coronary heart disease at 45
years old and patients 2 and 34 developed coronary heart disease.
The remaining members of the pedigree showed no abnormal
signs of related diseases, such as coronary heart disease, diabetes
mellitus, thyroid disorder, or hepatorenal disease. All pedigree
members had undergone a bland diet without smoking or drinking
alcohol.
Genome-wide linkage analysis
The nonparametric genome-wide scan revealed two prominent
signals with nonparametric linkage (NPL) scores of 9.01 (nominal
P,0.00001, and simulated occurrence per genome scan=1.08)
and 8.95 (nominal P,0.00001, and simulated occurrence per
genome scan=1.26) on chromosomes 3q25-26 and 21q22,
respectively (Figure 2), while no other genomic regions showed
NPL scores greater than 5. The significance levels of these two
NPL signals were of proximity to the standard of suggestive linkage
proposed by Lander & Kruglyak [11], where suggestive linkage is
statistical evidence that would be expected to occur one time at
random in a genome scan. The two highest LOD scores (both
were 1.45) of parametric genome-wide linkage analysis coincided
with the two NPL peak regions on chromosomes 3q25-26 and
21q22.
No linkage signals were found in those previously reported
regions for either autosomal dominant or recessive FH. The two
regions with prominent linkage signal, chromosomes 3q25-26 and
21q22, were used for further interaction analysis.
Haplotype analysis
To define the minimal co-segregating intervals on chromosomes
3q25-26 and 21q22 in our affected individuals, haplotypes were
constructed in the relevant genomic regions. The centromeric
boundary of the interval on 3q25-26 was defined by a
recombination event between SNP markers rs1920395 and
rs325762, which was observed in individual 7. The telomeric
boundary of this interval corresponded to a historic recombination
event between rs17782339 and rs1369276 in individual 2. These
recombination events defined the linkage signal on 3q25-26 to a
7.42 cM interval (160.00–167.42 cM; 152.45–165.64 Mb) be-
tween rs1920395 and rs1369276 (Figure 3A). On chromosome
21q22, the centromeric boundary was defined by recombination
events between rs220271 and rs876498 in individuals 7 and 37.
Thus, a 20-cM interval (59.28 cM-telomere; 42.36–46.90 Mb) on
chromosome 21 from rs220271 to the q telomere was defined
(Figure 3B). All the affected members shared both of the disease
linked haplotypes on 3q25-26 and 21q22. With these data from
our FH pedigree, we refined the linkage signals of the two
susceptibility loci to 3q25.1-26.1 and 21q22.3, respectively.
Notably, the disease linked haplotype on either locus was also
shared among some unaffected individuals. On chromosome
3q25-26, those individuals were 27, 28, and 21 (Figure 3A). On
chromosome 21q22, they were 1, 28, and 22 (Figure 3B). This
phenomenon suggests a possible incomplete penetrance of either
susceptibility locus.
Two-locus linkage analysis
The two-locus linkage analyses on 3q25-26 and 21q22 further
improved the linkage scores in both parametric and nonparametric
Table 1. Plasma lipid concentrations and clinical characteristics.
ID Sex Age TC TG LDL-C HDL-C ApoAI ApoB Xanthomas CHD FH diagnosis
(years) (mg/dl) (mg/dl) (mg/dl) (mg/dl) (g/L) (g/L)
1 Female 46 141.6 224.8 45.5 51.1 1.17 0.69 no no unaffected
2 Female 54 226.9 132.4 141 59.4 1.31 0.87 no yes affected
3 Male 56 146.7 132.4 62.6 57.6 1.28 0.71 no no unaffected
7 Female 28 290.6 270.3 166.5 70 1.47 0.68 no no affected
21 Male 33 102 129.4 31.4 44.7 1.24 0.55 no no unaffected
22 Male 32 148 134.8 60 61.1 1.55 0.62 no no unaffected
24 Female 57 317.9 195.6 220 58.8 1.04 0.79 no no affected
27 Male 32 146.1 100.9 62.1 63.8 1.35 0.58 no no unaffected
28 Female 26 104.2 65.5 29.1 62 1.25 0.46 no no unaffected
34 Male 50 260.2 262.6 152.1 55.6 1.27 1.04 no yes affected
35 Male 25 228.2 92.4 133.3 76.4 1.09 0.51 no no affected
36 Male 33 241.8 212.7 122.6 36.7 1.19 1.21 no no affected
37 Female 30 356.6 83.2 285.9 54.1 1.13 1.24 no no affected
38 Male 5 817.2 113.2 761.1 33.5 0.77 0.99 yes no affected
40 Female 48 290.6 148.6 176.2 84.7 1.49 0.85 no no affected
41 Male 22 241.2 129.4 58.2 157.1 1.29 0.94 no no affected
45 Female 30 285.6 123.9 186.4 74.4 1.18 0.89 no no affected
doi:10.1371/journal.pone.0024838.t001
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linkage analysis using a trimmed version of the pedigree (without
individuals 35, 40, and 41) under a multiplicative model yielded a
maximum joint LOD score of 2.70. This was a significant increase
over the single-locus LOD scores of 1.10 and 1.14 on chromosomes
3q25-26 and 21q22, respectively, with the same trimmed pedigree
structure. It was also observed that, the parametric two-locus
linkage analyses using a heterogeneous and an additive model
yielded LOD scores of 1.17 and 1.19, respectively, which are no
better than the single-locus LOD scores with the same trimmed
pedigree structure. Therefore, the interaction between these two
regions was better modeled by the multiplicative model. This
interaction was further supported by a joint NPL score (6.47;
P=0.000565) that was higher than those from single-locus analysis
on chromosomes 3q25-26 and 21q22 (4.09 and 4.47, respectively).
Candidate gene sequencing
We sequenced all the exons and intron-exon boundaries of two most
likely candidate genes ABCG1 and LSS on 21q22.3, using DNA samples
from 8 selected individuals of the pedigree. Five SNPs were detected in
the exons of LSS, including 2 synonymous SNPs, rs11558754 and
rs2254522, and 3 nonsynonymous SNPs, rs2254524, rs34115287, and
rs2839158. No SNPs were observed in the exons of ABCG1, however 6
SNPs were detected in the introns of ABCG1.N ode novo mutations or
indels were found in the sequenced regions of these genes. None of the
observed SNPs was related to the FH phenotype or was reported from
HapMap to be associated with diseases.
Discussion
Based on a genome-wide linkage scan of a Chinese pedigree
using SNP markers, we identified two suggestive linkage loci for
Figure 2. Genome-wide parametric and nonparametric linkage results of the FH pedigree. In the parametric linkage analysis, an
autosomal dominant model with a risk allele penetrance of 0.2 and a phenocopy rate of 0.0001 was assumed.
doi:10.1371/journal.pone.0024838.g002
Figure 1. Clinical manifestations of the proband that had a
typical FH phenotype (top panel). (A) Cutaneous xanthomas of
buttocks, (B) Cutaneous xanthomas on elbow region, (C) Tendinous
xanthomas and small cutaneous xanthomas of the hands, (D) Achilles
tendon xanthomas.
doi:10.1371/journal.pone.0024838.g001
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(13.19 Mb) between rs1920395 and rs1369276, and the other was
mapped to 21q22.3 in a 20-cM interval (4.54 Mb) from rs220271
to the q telomere. Both regions are distinct from the previously
reported candidate regions for both autosomal dominant and
recessive FH. Although the parametric linkage scores for both loci
were not significant, the nonparametric scores were suggestively
significant for both loci (nominal P,0.00001, with an occurrence
of about 1 time per genome scan). The main reason for the
insignificance of the parametric linkage score was the difficulty in
defining an accurate mode of inheritance. Incomplete penetranc-
es, phenocopies, or polygenic inheritance may also lead to loss of
power in single-locus parametric linkage mapping [12]. Non-
parametric linkage analysis has been described as a powerful
approach that can account for the possibility of alternative modes
of inheritance, and has been referred to as the method of choice
for pedigree studies of complex traits [13].
The two-locus model can greatly improve the power to detect
linkage for traits governed by two or more loci. The interaction
between the two uncovered loci on chromosomes 3q25-26 and
21q22 was suggested by both parametric and nonparametric two-
locus linkage analyses. Two-locus linkage analysis has been
successfully used to detect susceptibility loci for familial hypercho-
lesterolemia [7] and other complex traits, such as familial
combined hyperlipidemia [14], high factor VIII (FVIII) levels in
blood [15] and bipolar affective disorder [16]. In these studies, the
superiority of the two-locus linkage scores compared to the single-
locus scores was considered as evidence of genetic interaction. It is
regarded that the greater scores of two-locus linkage yields, the
stronger interaction between the examined loci. Our two-locus
linkage analysis supported the two linkage signals, and suggested a
multiplicative interaction between the two loci. The observed
haplotype transmission was also in agreement with the assumption
of two disease loci, because it reduced the number of unaffected
disease-linked haplotype carriers from 3 for single locus (either
3q25-26 or 21q22) to 1 for two loci (Figure 3). Thus, the genome-
wide linkage scan indicated a different and complex genetic basis
of FH for this pedigree compared with those previously reported.
There are 92 and 113 genes in the candidate regions of
chromosomes 3q25.1-26.1 and 21q22.3, respectively. We selected
the two most likely candidate genes ABCG1 and LSS for a
preliminary mutation screening. Both genes are located on
21q22.3. ABCG1 is a key gene involved in both cholesterol efflux
to HDL and tissue lipid homeostasis [17]. ABCG1 and ABCG4
act in concert with ABCA1 to maximize the removal of excess
cholesterol from cells and to generate cholesterol-rich lipoprotein
particles [18]. LSS encodes an enzyme that catalyzes the first step
of cholesterol biosynthesis, the conversion of (S)-2, 3 oxidosqualene
to lanosterol. Exon screening of both genes failed to identify any
mutation that co-segregated with the disease trait in this pedigree.
This result was not unexpected, because more than one gene was
implied in the pedigree according to our results. It is more
Figure 3. The most likely haplotypes of the FH pedigree on chromsomes 3q25-26 (A) and 21q22 (B). The black symbols indicated the
affected individuals. The red circles indicated critical recombinations. Marker names and their positions (cM) are listed on the left side.
doi:10.1371/journal.pone.0024838.g003
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than a single causative mutation, may contribute to FH.
Nevertheless, detailed screening for molecular variants in the
candidate genes should be carried out, perhaps with increased
screening size in a case-control design, and including extended
screening regions beyond exons. Indeed, recently a novel ABCG1
2257T.G promoter polymorphism that influences CHD severity
in Japanese males has been found [19].
In this study, the proband had a characteristic FH phenotype
with extremely high levels of plasma TC (817.2 mg/dl) and LDL-
C (761.1 mg/dl) and tendinous xanthomas, while the other
affected members had a relatively mild phenotype. Because both
parents were affected, one possibility was that the proband may
inherit two sets of pathogenic mutations (i.e., the maternal and
paternal mutations) in one gene or in different genes. Previous
clinical observations revealed that patients with compound
heterozygote LDLR mutations can exhibit a more severe FH
phenotype than their parents who carried only a single mutation
[20]. Unfortunately, the proband’s paternal family members were
unavailable for the linkage study. An intensive study of the family
members with next-generation sequencing technology should be
helpful in indentifying the molecular basis of the phenotype.
In summary, the SNP-based genome-wide linkage scan with a
Chinese FH pedigree revealed two suggestive linkage signals on
chromosomes 3q25.1-26.1 and 21q22.3. Both loci are distinct
from previously reported FH regions. Interaction analysis
assuming two disease loci suggested the involvement of more than
one locus in this pedigree. ABCG1 and LSS were identified as
plausible candidate genes in one of the candidate regions. Our
findings revealed new and complex genetic etiology for the disease.
Further research is advocated to identify the susceptibility genes in
these newly discovered candidate regions.
Materials and Methods
Ethics Statement
The study complies with the Declaration of Helsinki. All
participants provided written consent, and the ethics committee of
the Beijing Anzhen Hospital of the Capital University of Medical
Sciences approved all studies. Separate informed consent was
obtained to publish the photographs in Figure 1 from the guardian
of the proband.
Pedigree ascertainment and description
A 5-year-old boy with cutaneous vegetations on bilateral elbows,
knees, and buttocks was identified as the proband. A further
examination at the Beijing Anzhen Hospital found multiple
cutaneous and tendinous xanthomas in the boy (Figure 1). The
concentrations of plasma total cholesterol (TC) and LDL-
cholesterol (LDL-C) of the proband were 817.2 mg/dl and
761.1 mg/dl, respectively. Doppler ultrasound revealed increased
intima-media thickness and multiple atherosclerotic plaques in the
common carotid artery, right subclavian artery, abdominal aorta,
and femoral artery of the proband, especially in bifurcate region
and posterior walls of arteries.
An extended four-generation pedigree of the proband with 17
available members from Henan Province, China was obtained for
this study. All individuals had their lipoprotein measurements
recorded and general information such as gender, age, history of
smoking, dietary habits, personal history, and family history were
collected at the same time (Table 1). None of the parents were in a
consanguineous marriage. Individuals were evaluated clinically by
at least two cardiologists. In total, 11 individuals (5 males and
6 females) were diagnosed as FH-affected. All the affected
individuals, except individual 2, meet the criteria suggested by
Williams [21]. Individual 2 was diagnosed as ‘‘affected,’’ based on
her borderline high TC concentration (226.9 mg/dl), family
history, and positive status of CHD.
Serum lipids measurements
Venous blood samples were drawn from the pedigree members
after overnight fasting for 12 to 14 hours. The concentrations of
total plasma cholesterol, triglycerides, and high-density lipoprotein
cholesterol (HDL-C) were measured by applying standard
enzymatic techniques. The LDL-C concentration was calculated
by applying the Friedewald formula [22]. Levels of Apo AI and
Apo B100 were measured by ELISA.
Genotyping
Genomic DNA was extracted from venous blood of the 17
available pedigree members using a phenol-chloroform method.
Prior to the linkage scan, we excluded the possibility that any
known mutations from the three FH genes, LDLR, APOB, and
PCSK9, caused the FH phenotype of this pedigree. The LDLR gene
was examined by sequencing, whereas the APOB and PCSK9 loci
were examined by genotyping locus-linked microsatellite markers.
The genome-wide linkage scan was then conducted using the
Illumina Human Linkage-12 panel. The panel contains 6,090
single nucleotide polymorphism (SNP) markers that are well
spaced. Reactions were performed according to the manufactur-
er’s protocols. Fluorescent signals were scanned using Illumina’s
BeadStation; genotypes were called with Illumina BeadStudio
Software v3.1.8.
Genome-wide linkage analysis
Mendelian inconsistencies of the genotype data were investi-
gated with PEDCHECK v1.1 [23]. Unlikely double recombinants
were identified with the genotype error option of the linkage
software MERLIN v1.01. In our linkage analyses, either
monomorphic or non-Mendelian transmitted markers were
removed before analysis. Of the 6090 SNPs gentoyped, 5170
informative autosomal markers were used for linkage analysis. The
average genetic and physical distances between these markers were
0.69 cM and 557 kb, respectively. Both parametric and non-
parametric linkage analyses were performed using the linkage
software MERLIN v1.01 [24]. Parametric linkage analysis was
under an autosomal-dominant model with the following param-
eters: a risk allele frequency of 0.001, an incomplete penetrance of
0.2 for genotypes with 1 or 2 copies of the risk allele, and a
phenocopy rate of 0.0001. The low penetrance 0.2 was chosen for
the following two reasons: (i) the model with a penetrance of 0.2
gave higher LOD scores than the other tested models for both the
NPL-peak regions of the genome; and (ii) the disease transmission
patterns in the pedigree, including the existence of affected marry-
ins, unaffected offspring sharing putative disease-locus-linked
haplotype, and unknown affection status for deceased individuals,
indicated a low penetrance. The critical recombination events of
the pedigree members were determined through haplotype
construction in MERLIN v1.01.
Power estimation and simulation
The pedigree used in our study contained 17 genotyped
individuals with 11 affected and 6 unaffected members. Power
calculation was performed with SLINK [25], assuming an
autosomal-dominant model with penetrance of 0.95 and a
phenocopy rate of 0.001. The power to detect LOD scores
greater than 1 and 2 were 80% and 51%, respectively.
Suggestive Loci for Familial Hypercholesterolemia
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signal, we performed simulation studies of 1000 replicates
generated with the gene-dropping approach implemented in
MERLIN. In each simulation, marker allele frequencies, genetic
distances, pedigree structures, and missing data patterns were
retained. The number of simulations exhibiting equal or greater
linkage scores was used to calculate the frequency of the observed
linkage signal occurring by chance.
Two-locus linkage analysis
To test for an interaction between two putative loci on different
chromosomes, GENEHUNTER-TWOLOCUS software was
used to perform parametric and nonparametric linkage analysis
under two disease loci [26]. Three classes of interaction models
(heterogeneity, multiplicative, and additive) were tested according
to the method described by Strauch et al. The heterogeneity
model assumes that a mutation at either locus can cause the
phenotype by itself (‘‘or’’ condition). The multiplicative model
assumes that only mutations at both loci can cause the phenotype
(‘‘and’’ condition). As for the additive model, penetrances of a
single locus are simply added and rescaled to form two-locus
penetrances. Table 2 shows the two-locus penetrance we used in
this analysis. Because the two-locus analysis is computationally-
intense, to speed up the interaction test, the pedigree was trimmed
by removing the least-informative individuals 35, 40, and 41.
Candidate gene sequencing
Five affected and 3 unaffected pedigree members, including the
proband, his parents, his maternal uncles and aunts, and his
maternal grandparents, were selected for sequencing of the
candidate gene. All exons and intron-exon boundaries of the
two candidate genes, ABCG1 (15 exons) and LSS (23 exons) were
amplified with PCR and sequenced on ABI Prism 3730xl DNA
Analyzer.
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